FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating [...]

Vets First Choice Wins Approval to Build New Headquarters in Downtown Portland

Vets First Choice has received city approval to commence construction of a new headquarters in Portland, Maine to support its rapid growth and expansion. The new approximately 170,000 square foot facility will support more than [...]

Evox Therapeutics completes £35 million Series B financing

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the [...]

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-generation Antibody-based Therapeutics into the Clinic

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing [...]

Jesse Devitte

Contact Us

We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.

icon-phone 603.643.1500

icon-mail investors@borealisventures.com